DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxalt (Rizatriptan Benzoate) - Current Clinical Trials

 
 



Maxalt Related Clinical Trials

Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) [Completed]

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops [Withdrawn]

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache [Completed]

Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029) [Completed]

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7) [Completed]

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) [Completed]

Two Rizatriptan Prescribing Portions for Treatment of Migraine [Completed]

Rizatriptan for Episodic Dizziness in Vestibular Migraine [Recruiting]

A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3) [Completed]

A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis [Completed]

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? [Completed]

Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms. [Completed]

The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache [Completed]

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) [Completed]

Treatment of Multiple Attacks of Acute Migraine (0462-025) [Completed]

MK0462 in Treatment of Migraine With Recurrence (MK0462-022) [Completed]

Rizatriptan 10 MG RPD in the Treatment of Acute Migraine [Completed]

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) [Completed]

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) [Completed]

A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine [Completed]

A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) [Completed]

Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea [Completed]

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy [Completed]

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012) [Completed]

Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) [Completed]

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) [Completed]

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) [Completed]

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) [Completed]

Drug and Non-Drug Treatment Of Severe Migraine [Completed]

Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine [Completed]

Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy [Completed]

A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data [Completed]

Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017